Engineered Dual Binding Antibodies and Uses Thereof
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,686,714 | Engineered Dual Binding Antibodies and Uses Thereof In force · High confidence | Biolojic Design Ltd. | In force | High confidence | ||
| Application 18/262,419 | Dual Binding Antibodies, Methods of Producing Dual Binding Antibodies, and Uses Thereof Pending Not granted | Biolojic Design Ltd. | Pending | Not granted | ||
| Application 19/700,775 | Engineered Dual Binding Antibodies and Uses Thereof Pending Not granted | Biolojic Design Ltd. | Pending | Not granted |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Biolojic Design Ltd..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.